human | Q5 |
P106 | occupation | researcher | Q1650915 |
Q35986133 | Abatacept decreases disease activity in a absence of CD4(+) T cells in a collagen-induced arthritis model. |
Q44288937 | Activation of human basophils by combined toll-like receptor- and FcεRI-triggering can promote Th2 skewing of naive T helper cells |
Q33904381 | Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis |
Q91844477 | Antibody-Dependent Natural Killer Cell Activation after Ebola Vaccination |
Q58234739 | Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune system |
Q38820148 | Breach of autoreactive B cell tolerance by post-translationally modified proteins |
Q40011968 | Coronaviruses as vectors: position dependence of foreign gene expression |
Q43857742 | DX5+ CD4+ T cells modulate CD4+ T-cell response via inhibition of IL-12 production by DCs. |
Q37908887 | Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models? |
Q92114738 | Ebola virus glycoprotein stimulates IL-18 dependent natural killer cell responses |
Q43490125 | IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody production |
Q57004818 | Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B |
Q79447368 | Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B |
Q54513978 | Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. |
Q39338146 | Low-strength T-cell activation promotes Th17 responses. |
Q37001999 | Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile |
Q44447870 | Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. |
Q85220606 | The choice of adjuvant determines the cytokine profile of T cells in proteoglycan-induced arthritis but does not influence disease severity |
Q60061990 | Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses |
Q45401519 | Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response |
Search more.